Organigram Holdings Inc , through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada.
infoOrganiGram is a micro cap stock with a total market cap of 122.35M.
infoThey trade on the NASDAQ and had their IPO 4 years and 3 months ago.
infoOrganiGram currently employs 923 people.
infoAs of Wednesday, Aug 23 2023, OrganiGram’s share price is $1.45.
News Relating to OrganiGram
InvestorPlace
3 Cannabis Stocks to Snap Up Before They Skyrocket
Sunday Aug 20 2023 at 13:38
Despite the ongoing challenges, the cannabis industry has been responsive to innovation, growth, and transformation. The article lists three key players poised to capitalize on unique aspects of the cannabis market.
MarijuanaStocks
Mid-August 2023 Watchlist: Promising Canadian Cannabis Penny Stocks for Traders
Wednesday Aug 16 2023 at 21:10
As Canada’s cannabis sector grows, knowledgeable investors look for chances in marijuana penny stocks in 2023. These lower-priced stocks have the potential for quick gains, making them tempting to day traders and swing traders looking for quick profits. However, approaching this market with prudence and a strong plan that includes good risk management and technical analysis to understand the peculiar characteristics of penny stocks is critical.
MarijuanaStocks
Top Canadian Cannabis Stocks To Watch In August 2023
Thursday Aug 10 2023 at 14:00
In August 2023, the Canadian cannabis sector and top marijuana stocks attracted the attention of many investors. The quarterly cannabis earnings season has begun, providing light on the financial performance and growth prospects of Canada’s biggest cannabis companies. This critical juncture offers investors a unique chance to examine the industry’s current picture and contemplate strategic holdings in leading Canadian cannabis stocks. With the cannabis industry quickly expanding, knowledgeable traders are navigating the subtleties of short- and long-term trading methods while utilizing technical analysis to maximize entry and exit points.
MarijuanaStocks
3 Canadian Marijuana Stocks To Watch For Gains In August
Friday Aug 04 2023 at 13:30
There has been more acceptance of cannabis use over the years. This has led to finding ways to invest in the industry. In addition to seeing an increase in cannabis consumption whether it’s smoking or edibles. Which all carry great potential and profits for various cannabis companies. If you are somebody who is following the sector or even just getting involved here are some things to know. Before you begin searching for marijuana stocks to buy you should follow a few steps.
MarijuanaStocks
The Top Marijuana Stocks Of The Cannabis Sector
Wednesday Jul 19 2023 at 07:00
Marijuana stocks could be the investment of the future people are looking for. As companies prepare to release earnings once again investors are keeping watch on the sector. The cannabis industry is still young and developing which brings the potential for more investment opportunities. Over the last half a decade there has been tremendous growth and progress for many cannabis companies. With the continued success of legal cannabis throughout the US it intrigues others to consider investing in top marijuana stocks.
Seeking Alpha
Organigram Is Still My Favorite Cannabis Stock
Monday Jul 17 2023 at 02:31
I have followed Organigram closely since it went public in 2014. The Q3 report on 7/13 was a disaster on two fronts. I find the valuation currently to be extremely cheap, and OGI is the largest position in my model portfolio.
MarijuanaStocks
3 Top Marijuana Stocks Of 2023 To Watch Right Now
Friday Jul 14 2023 at 13:33
Marijuana stock investors are always on the lookout for their next opportunity. In the cannabis industry that can be at any time with how young and volatile things are. Right now the cannabis sector is seeing the level of price fluctuation on the publicly traded side of the business. What this means is certain marijuana stocks are showing a trading pattern that is a bit more unpredictable. Nevertheless, the industry is still progressing and growing which provides hope for future investing.
Seeking Alpha
Organigram Holdings Inc. (OGI) Q3 2023 Earnings Call Transcript
Friday Jul 14 2023 at 11:57
Organigram Holdings Inc. (NASDAQ:OGI ) Q3 2023 Earnings Conference Call July 14, 2023 8:00 AM ET Company Participants Max Schwartz – Director, IR Beena Goldenberg – CEO Tim Emberg – Chief Commercial Officer Derrick West – CFO Conference Call Participants Tamy Chen – BMO Frederico Gomes – ATB Capital Markets Aaron Grey – Alliance Global Partners Andrew Partheniou – Stifel GMP Ty Collin – Eight Capital Operator Good morning. My name is Rob, and I will be your conference operator today.
InvestorPlace
3 Doomed Stock-Split Stocks Destined for Disaster
Friday Jul 14 2023 at 08:39
Stock Split is a regular occurrence within the stock market. However, they are much more common among stocks at risk of being delisted from an exchange such as NASDAQ due to minimum bid requirements that revolve around a company’s share price.
Business Wire
Organigram to Report Third Quarter Fiscal 2023 Results on July 13, 2023
Friday Jul 07 2023 at 20:00
TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2023 ended May 31, 2023, on Thursday, July 13, 2023, after market close. The Company will host a conference call to discuss its results with details as follows: Date: Friday, July 14, 2023 Time: 8:00 am Eastern Time To regi.
MarijuanaStocks
Top Canadian Cannabis Stocks to Watch in 2023: Investing in the Booming Cannabis Industry
Wednesday Jun 28 2023 at 14:00
The Canadian cannabis industry and top marijuana stocks continue to evolve and thrive as we approach July 2023. Since the legalization of recreational cannabis in Canada in 2018, the business has developed dramatically, attracting both investors and users. Cannabis legalization has paved the way for a thriving market, with numerous firms vying for a piece of the rapidly expanding industry. Cannabis stocks in Canada continue to offer lucrative investment options. This article will examine the current state of the three Canadian cannabis companies, the industry’s challenges, advancements in safe banking, and the prospects for trading Canadian cannabis stocks in 2023.
Zacks Investment Research
Organigram (OGI) Grows in Cannabis Space With SHRED X Heavies
Tuesday Jun 27 2023 at 09:48
Organigram’s (OGI) SHRED X Heavies is not only the first infused pre-roll in the SHRED product portfolio but also joins a lineup of value-driven, convenient and bold-flavored offerings.
MarijuanaStocks
The Global Influence On Marijuana Stocks And The Cannabis Industry
Tuesday Jun 20 2023 at 07:00
International markets are playing a significant role in shaping the future of the cannabis industry. Countries such as Canada, Uruguay, and several European nations have already legalized cannabis for both medical and recreational purposes. This has created new opportunities for businesses to expand their operations globally. Especially for certain marijuana stocks in the market where the volatile trading is heavy.
MarijuanaStocks
3 Canadian Marijuana Stocks To Add To Your Trading Portfolio
Tuesday Jun 13 2023 at 07:00
For some time now the cannabis sector has experienced significant volatility, which has affected how most marijuana stocks trade. The sector has also shown signs of maturing and working to become more stable over time. As regulatory frameworks become clearer and the industry further consolidates, some of the extreme fluctuations may subside. However, it is important to recognize that the cannabis sector remains subject to ongoing developments and regulatory changes.
MarijuanaStocks
Top Canadian Penny Stocks To Buy? 3 To Watch
Wednesday Jun 07 2023 at 11:30
As the global cannabis sector gains traction, Canadian cannabis stocks remain at the vanguard, providing investors with attractive options in a quickly expanding market. The cannabis sector in Canada has grown dramatically, attracting investors from all walks of life. The country’s forward-thinking approach to cannabis legalization, as well as its strong regulatory structure, have created a climate that encourages growth, innovation, and profitability. As a result, with companies at various phases of development and diversification, Canadian cannabis stocks have emerged as an interesting investment opportunity.
MarijuanaStocks
3 Marijuana Stocks To Watch Right Now In June
Tuesday May 30 2023 at 07:00
Marijuana stock investors are on high alert. The reason is many who are invested in cannabis are watching for the next recovery. Much of the sector has faced the same fate of seeing more pullback than upward trading. Now even with more chances to find the best marijuana stocks to buy people want to see better trading. A handful of investors feel that you can still play the market when a volatile pop occurs. Yet the inconsistency makes it tough to predict when that will be. Especially with increasing concerns about new rules and regulatory issues.
Seeking Alpha
Don’t Avoid All Canadian Cannabis Producers
Monday May 29 2023 at 08:15
Canadian LPs are now down in 2023 and down a lot since 2018. The two most popular LPs, Canopy Growth and Tilray, have imploded. Some Canadian LPs are trading very cheaply and could do better.
MarijuanaStocks
Canadian Cannabis Stocks Under $2 To Watch Now
Thursday May 18 2023 at 17:30
Canadian Pot Stocks To Watch In May The post Canadian Cannabis Stocks Under $2 To Watch Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
MarijuanaStocks
2 Marijuana Stocks To Buy In Todays Stock Market?
Monday Apr 24 2023 at 08:39
Top 2 Marijuana Stocks For Investing In Legal Cannabis The post 2 Marijuana Stocks To Buy In Todays Stock Market? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
MarijuanaStocks
3 Stocks To Buy In The Stock Market On 420
Thursday Apr 20 2023 at 07:00
The Best 3 Marijuana Stocks Right Now In The Market The post 3 Stocks To Buy In The Stock Market On 420 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
The Motley Fool
Why Organigram Holdings Stock Is Plummeting Today
Wednesday Apr 12 2023 at 14:01
Organigram’s Q2 sales and earnings performance fell short of the market’s expectations. While the company did manage to grow its adjusted gross margin and EBITDA, pricing compression is hurting revenue.
Proactive Investors
Organigram’s strong international sales growth during 2Q cause for optimism, Stifel analysts say
Wednesday Apr 12 2023 at 12:51
Organigram’s latest quarterly results demonstrated the strength of its international sales growth while its performance in the recreational (REC) segment was weak, analysts at Stifel GMP highlighted. In a note to clients, the analysts observed that the Moncton, New Brunswick-based cannabis producer’s fiscal second quarter 2023 results were mixed, missing on revenues but with significantly higher than expected gross margins.
Proactive Investors
Organigram shares fall as 2Q results fail to fire up investors
Wednesday Apr 12 2023 at 07:51
OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) has reported second-quarter revenue and earnings that fell short of analyst estimates, sending its shares lower in Wednesday pre-market trade. However, the cannabis producer noted that its gross profit margins improved as it increased efficiencies and sold more product, including higher international sales.
Zacks Investment Research
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
Tuesday Apr 11 2023 at 22:10
OrganiGram (OGI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.02 per share a year ago.
The Motley Fool
Which Canadian Cannabis Company Will Be the Next Takeover Target?
Tuesday Apr 11 2023 at 09:45
A thriving black market and a glut of legal operators have weighed on profit margins in the Canadian cannabis space. This key pressure is likely to drive a wave of consolidation across the industry in the years to come.
The Motley Fool
Why Organigram Holdings Stock Is Perking Up Today
Monday Apr 10 2023 at 15:32
With two Canadian cannabis earnings results announcements set to kick off this week, Organigram’s shares are solidly in the green today. The company’s stock got an additional boost from a renewed call to expedite the ongoing scheduling review for cannabis in the United States.
Proactive Investors
Tilray and Organigram to report earnings: can either cannabis company deliver an upside surprise?
Thursday Apr 06 2023 at 15:50
After a tough 2022 for cannabis stocks, investors will be looking to companies such as Tilray Brands and Organigram Holdings as they report their latest quarterly results to see how the industry is faring in the first three months of 2023. New York-based Tilray is set to report its 3Q fiscal 2023 results after the market close on April 10, but analysts aren’t too optimistic about the company’s recent performance.
Business Wire
Organigram to Report Second Quarter Fiscal 2023 Results on April 11, 2023
Tuesday Apr 04 2023 at 06:00
TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2023 ended February 28, 2023, on Tuesday, April 11, 2023, after market close.
MarijuanaStocks
Don’t Be An April Fool 2 Marijuana Stocks To Buy?
Monday Apr 03 2023 at 11:03
Top Marijuana Stocks To Watch The First Week Of April The post Don’t Be An April Fool 2 Marijuana Stocks To Buy? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
MarijuanaStocks
Top Marijuana Stocks To Watch Right Now In 2023
Tuesday Mar 28 2023 at 07:00
Top Marijuana Stocks To Know About This Month The post Top Marijuana Stocks To Watch Right Now In 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
OrganiGram Bankruptcy Risk
The Altman Z-score is a formula that measures a company’s financial health and bankruptcy risk. It assigns a numerical score based on various financial ratios. The Z-score is divided into different zones. If the Z-score is above 2.99, it indicates a lower bankruptcy risk, classifying the company as ‘safe’ or ‘non-distressed’. If the score falls below 1.81, it suggests a higher risk, indicating potential financial distress or bankruptcy. The range between 1.81 and 2.99 is called the ‘gray zone’ or zone of ambiguity.
Learn more at Investopediaopen_in_new
OrganiGram’s Altman Z-score is 0.63 which is in the distress zone. This indicates a higher risk of financial distress and potential bankruptcy for the company. It can serve as a warning sign of significant financial challenges, requiring careful consideration by potential investors.
Derived from SEC.GOV filing dataopen_in_new
OrganiGram Insider Trading
Insider trading is when individuals employed by a company buy or sell its securities following legal procedures and regulations. Company executives, directors, and employees may be permitted to buy or sell shares if they follow specific rules, such as filing a Form 4 with the SEC within two business days.
Learn more at Investopediaopen_in_new
Over the last 3 months, there has been no insider trading in OrganiGram.
Derived from SEC.GOV filing dataopen_in_new
Debt & Income Analysis
Income quality measures a company’s operating cash flow to net income ratio. It helps investors and analysts assess the sustainability of a company’s earnings. A high QIR indicates strong cash flows, while a low QIR may indicate non-operating activities driving net income.
Learn more at WallStreetPrepopen_in_new
OrganiGram’s Income Quality of 0.19 is lower than its Industry Group of 0.69 (-72.5% lower)
OrganiGram’s Income Quality of 0.19 is lower than its Major Industry Group of 0.71 (-73.2% lower)
OrganiGram’s Income Quality of 0.19 is lower than its Sector of 0.75 (-74.7% lower)
Derived from SEC.GOV filing dataopen_in_new
Current ratio measures a company’s ability to pay off short-term debt with its current assets (assets that a company expects to use up or convert to cash within a year). It represents the $ amount of current assets a company has for every $1 of short-term debt. A high current ratio above 1.0 indicates that a company can meet its short-term obligations, while a low current ratio below 1.0 suggests difficulty.
Learn more at Investopediaopen_in_new
OrganiGram’s Current Ratio of 4.54 is in line with its Industry Group of 4.76 (-4.6% lower)
OrganiGram’s Current Ratio of 4.54 is in line with its Major Industry Group of 4.32 (5.1% greater)
OrganiGram’s Current Ratio of 4.54 is greater than its Sector of 2.6 (74.6% greater)
Derived from SEC.GOV filing dataopen_in_new
Value Analysis
PE ratio (price-to-earnings), measures a company’s stock price relative to its earnings per share. It helps investors evaluate whether its stock is overvalued or undervalued. A higher PE ratio indicates that investors are willing to pay more for a company’s earnings, while a lower PE ratio (above zero) suggests the company could be undervalued.
Learn more at Investopediaopen_in_new
Cannot compare a negative PE Ratio (-0.75 & -1.27)
Cannot compare a negative PE Ratio (-0.75 & -1.1)
Cannot compare a negative PE Ratio (-0.75 & -0.4)
Derived from SEC.GOV filing dataopen_in_new
The PB ratio (price-to-book), measures a company’s stock price relative to its book value (net value of a company’s assets reported on its balance sheet, after subtracting debt) per share. It is used to evaluate a company’s valuation, with a lower PB ratio (above zero) indicating a lower valuation and a higher PB ratio suggesting overvaluation.
Learn more at Investopediaopen_in_new
OrganiGram’s PB Ratio of 0.55 is lower than its Industry Group of 1.34 (-59.0% lower)
OrganiGram’s PB Ratio of 0.55 is lower than its Major Industry Group of 1.4 (-60.7% lower)
OrganiGram’s PB Ratio of 0.55 is lower than its Sector of 1.62 (-66.0% lower)
Derived from SEC.GOV filing dataopen_in_new
Efficiency Analysis
ROE (Return on Equity), is a financial ratio that measures a company’s profitability relative to its shareholders’ equity (the amount of value in a company that belongs to the people who own shares). It indicates how efficiently a company generates profits per unit of equity invested. A high ROE suggests effective use of equity, while a low ROE indicates inefficiency.
Learn more at Investopediaopen_in_new
OrganiGram’s ROE of -0.73 is lower than its Industry Group of -0.44 (-65.9% lower)
OrganiGram’s ROE of -0.73 is lower than its Major Industry Group of -0.38 (-92.1% lower)
OrganiGram’s ROE of -0.73 is lower than its Sector of -0.03 (-2333.3% lower)
Derived from SEC.GOV filing dataopen_in_new
ROCE (Return on Capital Employed), is a financial ratio that measures a company’s profitability relative to the amount of capital invested in its operations. It indicates how well a company is generating profits from its capital investments. A high ROCE suggests effective use of capital, while a low ROCE indicates inefficiency.
Learn more at Investopediaopen_in_new
OrganiGram’s ROCE of -0.75 is lower than its Industry Group of -0.42 (-78.6% lower)
OrganiGram’s ROCE of -0.75 is lower than its Major Industry Group of -0.37 (-102.7% lower)
OrganiGram’s ROCE of -0.75 is lower than its Sector of -0.04 (-1775.0% lower)
Derived from SEC.GOV filing dataopen_in_new